Literature DB >> 20579522

Satiereal, a Crocus sativus L extract, reduces snacking and increases satiety in a randomized placebo-controlled study of mildly overweight, healthy women.

Bernard Gout1, Cédric Bourges, Séverine Paineau-Dubreuil.   

Abstract

Snacking is an uncontrolled eating behavior, predisposing weight gain and obesity. It primarily affects the female population and is frequently associated with stress. We hypothesized that oral supplementation with Satiereal (Inoreal Ltd, Plerin, France), a novel extract of saffron stigma, may reduce snacking and enhance satiety through its suggested mood-improving effect, and thus contribute to weight loss. Healthy, mildly overweight women (N = 60) participated in this randomized, placebo-controlled, double-blind study that evaluated the efficacy of Satiereal supplementation on body weight changes over an 8-week period. Snacking frequency, the main secondary variable, was assessed by daily self-recording of episodes by the subjects in a nutrition diary. Twice a day, enrolled subjects consumed 1 capsule of Satiereal (176.5 mg extract per day (n = 31) or a matching placebo (n = 29). Caloric intake was left unrestricted during the study. At baseline, both groups were homogeneous for age, body weight, and snacking frequency. Satiereal caused a significantly greater body weight reduction than placebo after 8 weeks (P < .01). The mean snacking frequency was significantly decreased in the Satiereal group as compared with the placebo group (P < .05). Other anthropometric dimensions and vital signs remained almost unchanged in both groups. No subject withdrawal attributable to a product effect was reported throughout the trial, suggesting a good tolerability to Satiereal. Our results indicate that Satiereal consumption produces a reduction of snacking and creates a satiating effect that could contribute to body weight loss. The combination of an adequate diet with Satiereal supplementation might help subjects engaged in a weight loss program in achieving their objective. Copyright 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20579522     DOI: 10.1016/j.nutres.2010.04.008

Source DB:  PubMed          Journal:  Nutr Res        ISSN: 0271-5317            Impact factor:   3.315


  19 in total

Review 1.  Anti-obesogenic and antidiabetic effects of plants and mushrooms.

Authors:  Jan Martel; David M Ojcius; Chih-Jung Chang; Chuan-Sheng Lin; Chia-Chen Lu; Yun-Fei Ko; Shun-Fu Tseng; Hsin-Chih Lai; John D Young
Journal:  Nat Rev Endocrinol       Date:  2016-09-16       Impact factor: 43.330

Review 2.  A systematic review of randomized controlled trials examining the effectiveness of saffron (Crocus sativus L.) on psychological and behavioral outcomes.

Authors:  Heather Ann Hausenblas; Kacey Heekin; Heather Lee Mutchie; Stephen Anton
Journal:  J Integr Med       Date:  2015-07

3.  A systematic review of anti-obesity medicinal plants - an update.

Authors:  Shirin Hasani-Ranjbar; Zahra Jouyandeh; Mohammad Abdollahi
Journal:  J Diabetes Metab Disord       Date:  2013-06-19

Review 4.  Saffron: A Natural Potent Antioxidant as a Promising Anti-Obesity Drug.

Authors:  Maryam Mashmoul; Azrina Azlan; Huzwah Khaza'ai; Barakatun Nisak Mohd Yusof; Sabariah Mohd Noor
Journal:  Antioxidants (Basel)       Date:  2013-10-29

5.  Acute and subacute toxicity of safranal, a constituent of saffron, in mice and rats.

Authors:  Hossein Hosseinzadeh; Saied Sadeghi Shakib; Abbas Khadem Sameni; Elahe Taghiabadi
Journal:  Iran J Pharm Res       Date:  2013       Impact factor: 1.696

Review 6.  Razi's Al-Hawi and saffron (Crocus sativus): a review.

Authors:  Hamid Mollazadeh; Seyyed Ahmad Emami; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2015-12       Impact factor: 2.699

7.  A double-blind placebo-controlled randomized trial of oral saffron in the treatment of rheumatoid arthritis.

Authors:  Maryam Sahebari; Hossein Heidari; Shima Nabavi; Mandana Khodashahi; Zahra Rezaieyazdi; Maliheh Dadgarmoghaddam; Hossein Hosseinzaheh; Shaghayegh Abbasi; Kamila Hashemzadeh
Journal:  Avicenna J Phytomed       Date:  2021 Jul-Aug

Review 8.  Inhibitors of pancreatic lipase: state of the art and clinical perspectives.

Authors:  Nitin A Lunagariya; Neeraj K Patel; Sneha C Jagtap; Kamlesh K Bhutani
Journal:  EXCLI J       Date:  2014-08-22       Impact factor: 4.068

9.  Saffron and crocin improved appetite, dietary intakes and body composition in patients with coronary artery disease.

Authors:  Nasim Abedimanesh; S Zahra Bathaie; Saeed Abedimanesh; Behrooz Motlagh; Ahmad Separham; Alireza Ostadrahimi
Journal:  J Cardiovasc Thorac Res       Date:  2017-12-30

10.  The Efficacy of Crocin of Saffron (Crocus sativus L.) on the Components of Metabolic Syndrome: A Randomized Controlled Clinical Trial.

Authors:  Tayyebe Kermani; Toba Kazemi; Somayye Molki; Khadije Ilkhani; Gholamreza Sharifzadeh; Omid Rajabi
Journal:  J Res Pharm Pract       Date:  2017 Oct-Dec
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.